Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
The Laryngoscope|May 1, 1990
Randomized comparison of two chemotherapy, radiotherapy schemes for stage III and IV unresectable squamous cell carcinoma of the head and neckM Merlano, R Rosso, M R Sertoli, et al.
Cancer|February 15, 1991
Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. The final report of a randomized trialM Merlano, R Corvo, G Margarino, et al.
American Journal of Clinical Oncology|February 1, 1989
Recombinant alpha-2a interferon plus vinblastine in the treatment of metastatic renal cell carcinomaM R Sertoli, I Brunetti, A Ardizzoni, et al.
American Journal of Clinical Oncology|December 1, 1993
Second-line hormonotherapy for breast cancer. Uselessness of first-line continuationP Pronzato, A Rubagotti, D Amoroso, et al.
Acta Medica Austriaca|January 1, 1989
Intraperitoneal infusion of recombinant interleukin-2 in malignant ascites in patients with gastrointestinal and ovarian cancerS Bertoglio, G Melioli, E Baldini, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|October 1, 1987
Cisplatin and cyclophosphamide in early epithelial ovarian carcinomaS Chiara, P F Conte, M Bruzzone, et al.
Tumori|November 6, 2001
A feasibility study using polychemotherapy (cisplatin + vindesine + dacarbazine) plus interferon-alpha or monochemotherapy with dacarbazine plus interferon-alpha in metastatic melanomaE Bajetta, M Del Vecchio, M Vitali, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Adjuvant cisplatin-based chemotherapy for stage I and II ovarian cancer: a 7-year experienceS Chiara, S Mammoliti, C Oliva, et al.
Anticancer Research|September 1, 1992
Prognostic factors in node positive primary breast cancer patients treated with adjuvant CMFE Campora, P Pronzato, D Amoroso, et al.
Melanoma Research|April 1, 1994
Proliferative, phenotypic and functional and molecular characteristics of tumour-infiltrating lymphocytes obtained from unselected patients with malignant melanomas and expanded in vitro in the presence of recombinant interleukin-2G Melioli, M Guastella, C Semino, et al.
Pageof 8